Drug Trial Radar · NCT05298046
Study of TAVO101 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Nov 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
May 11, 2022
Primary completion
Jun 1, 2024
Study completion Sep 30, 2024
Sponsor
- Lead sponsor
- Tavotek BiotherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, single ascending dose study designed to investigate TAVO101, administered as an IV infusion in healthy subjects. This study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAVO101.
Conditions
- Healthy Subjects
Interventions
Experimental: TAVO101Drug
TAVO101 single ascending dose IV infusion.
Other: PlaceboOther
Placebo single ascending dose IV infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The severity of adverse effects according to the National Cancer Institute's Common Terminology Criteria for AEs, Version 5.0 [Time Frame: Day 1 through Day 196]Time frame: 196 days
- Changes in vital signs including oral temperature or tympanic temperature (C°) [Time Frame: Day 1 through Day 196]Time frame: 196 days
- Changes in vital signs including respiratory rate (breaths per minute) [Time Frame: Day 1 through Day 196]Time frame: 196 days
- Changes in vital signs including systolic and diastolic blood pressure (mmHg) [Time Frame: Day 1 through Day 196]Time frame: 196 days
- Changes in vital signs including pulse rate (beats per minute) [Time Frame: Day 1 through Day 196]Time frame: 196 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.